New research from Tokyo, Japan could help clarify the role of proinflammatory mediators in the pathogenesis of chronic inflammatory myopathies, such as polymyositis and dermatomyositis.

ULSCs is under clinical development by RESTEM and currently in Phase I for Polymyositis. According to GlobalData, Phase I drugs for Polymyositis does not have sufficient historical data to build an ...

ULSCs is under clinical development by RESTEM and currently in Phase I for Dermatomyositis. According to GlobalData, Phase I drugs for Dermatomyositis have a 91% phase transition success rate (PTSR) ...

Medically reviewed by Dale Garber, MDJuvenile myositis (JM) affects those under the age of 18 years. JM is known for causing ...

Keep abreast with the latest news related to Polymyositis there are 13 news items on Polymyositis that covers updates, breakthroughs and in-depth reports. We provide you with a free downloadable ...

These investigators explored how knowing the distinctive features of dermatomyositis in Black adults, which may be subtle, could possibly lead to faster and more accurate diagnosis. To tackle the ...

Other rheumatological diseases that can increase cancer risk include polymyositis and dermatomyositis. Polymyositis is ...

CORONA, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- RESTEM – a clinical-stage biotechnology company that develops off-the-shelf, next-generation cell therapies designed to modulate the immune ...

There are different types of Myositis — Polymyositis and Dermatomyositis are the most common ones. Popular actress Samantha Prabhu, last week, announced on Instagram that she was suffering from ...

- Oral presentation at ACR highlights safety and efficacy data from the Phase 1 trial of umbilical cord outer lining-derived stem cells (ULSCs) in patients with ...

Polymyositis is an autoimmune disease that causes inflammation and weakness of the skeletal muscles responsible for movement. Dermatomyositis is a form of polymyositis that is associated with skin ...